drugset / Trial / NCT04433494
A Study of TY-302 in Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
The primary objective of this study is to evaluate the safety and tolerability of TY-302 single and the combination with Tamoxifen in dose-escalation and dose-expansion study.The drugs involved in this study are: * TY-302 * Tamoxifen
Timeline
- Start
- 2020-12-07
- Primary completion
- 2023-05
- Completion
- 2023-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tamoxifen | Small molecule | 20 mg | Oral |
| Subject | Tamoxifen | Small molecule | 25 mg | Oral |
| Subject | Tamoxifen | Small molecule | 50 mg | Oral |